Inflammatory Bowel Diseases

15th Congress of ECCO, February 12-15, 2020, Vienna/Austria

Pocket Guide Changes Page

Scientific Programme

Scientific Session 9: Basic Science: Big Data research
Sebastian Zeissig, Dresden, Germany
Laurence Egan, Galway, Ireland


55: OP32: Mincle signaling promotes intestinal mucosal inflammation through induction of macrophage pyroptosis and neutrophil chemotaxis in Crohn's Disease


Scientific Session 10: Multidisciplinary cases
Dan Turner, Jerusalem, Israel
Marc Ferrante, Leuven, Belgium
Pierre Michetti, Lausanne, Switzerland
Yves Panis, Clichy, France
Frank Ruemmele, Paris, France

Digital Oral Presentation Session 2 -
Assessment of disease and therapy response 

DOP15: Transmural healing with vedolizumab in patients with active Crohn's Diesease
Shaji Adsul


DOP16: An evaluation of the exposure-efficacy relationship for subcutaneous vedolizumab maintenance treatment of Chron's Diesease: Pharmacokinetic findings from VISIBLE 2
Maria Rosario

Digital Oral Presentation Session 3 -
Improving care of IBD

DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months
Jason Rogers, New York, United States


DOP23: Endoscopic evaluation at one month after Ileocolic resection for Crohn's Disease predicts postoperative recurrence and is safe

Digital Oral Presentation Session 6 -
New insights into pathogenesis of IBD

DOP49: Quantitative proteomics analysis of macrophages from Crohn's Disease patients and infected with adherent-invasive Escherichia coli
Anthony Buisson, Clermont-Ferrand, France

Digital Oral Presentation Session 8 -
Current and novel targets for IBD agents

DOP66: A CEACAM5 small peptide restores the suppressive activity of CD8 + T cells in patients with Crohn's Disease
Stefania Vetrano, Rozzano, Italy


DOP68: Thiomyristoyl Ameliorates Colitis by blocking the differentiation of Th17 Cells via STAT3/IL-6 Signal Pathway

Digital Oral Presentation Session 10 -
Fighting the F's: Fat and fibrosis in IBD

DOP90: The role of Nlrp9b, a novel NLR member in regulating experimental colitis

Educational Programme

6th Y-ECCO Basic Science Workshop


Whole blood TREM-1, marker of anti-TNF non-responsiveness in IBD
Bram Verstockt, Leuven, Belgium

14th N-ECCO Network Meeting


N01:Factors related to self-medication with corticosteroids, aminosalicylates or analgesics and reasons given by patients with Ulcerative Colitis from Spain

Sabela Fernandez, Madrid, Spain

We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.